PulmOne

Desktop Device for Pulmonary Function Testing

Health Tech & Life Sciences
Active
Series A Ra'anana, Israel Founded 2006
Website ↗ LinkedIn
Last updated 2026-06-18
Total raised
$13.7M
Last: 2022-03
Stage
Series A
Founded
2006
Headcount
53
HQ
Ra'anana, Israel
Sector
Health Tech & Life Sciences

About

PulmOne develops patient-friendly, hassle-free, and budget-conscious devices designed to accurately inform clinical decision making throughout the diagnosis, treatment, and monitoring of respiratory diseases. The company's MiniBox is a system for measuring lung volume and spirometry. It is a desktop device designed to provide an accurate assessment of lung volume based on normal tidal breathing and a short measurement time. The system does not rely on a plethysmograph or external gas source. PulmOne's MiniBox+ adds to the spirometry and LVM tests with a diffusing capacity (DLCO) module, providing a complete solution. The company has received FDA 510k clearance and a CE mark for its first product and started sales in several locations.

Funding history · 5 rounds · $13.7M total

2022-03
$4.0M
OurCrowd
2021-12
2017-06
$1.2M
OurCrowd
2015-04
$2.8M
★ OurCrowd
2013-05
$1.6M
★ OurCrowd

Q&A

What is PulmOne's primary business?
PulmOne develops patient-friendly, hassle-free, and budget-conscious desktop devices for pulmonary function testing, designed to accurately inform clinical decision-making for respiratory diseases.
What products does PulmOne offer?
PulmOne offers the MiniBox, a system for measuring lung volume and spirometry, and the MiniBox+, which adds a diffusing capacity (DLCO) module to the spirometry and LVM tests for a complete solution.
When was PulmOne founded?
PulmOne was founded in March 2006.
What is PulmOne's total funding to date?
PulmOne has raised a total of $13,709,406 USD.
When was PulmOne's most recent funding round and who participated?
PulmOne's most recent funding round occurred in March 2022, raising $4,000,000 USD, with participation from OurCrowd.
Which investors participated in PulmOne's December 2021 funding round?
In December 2021, PulmOne raised $4,000,000 USD in a round led by Alpha LTI, with participation from OurCrowd.
Has PulmOne received regulatory clearances for its products?
Yes, PulmOne has received FDA 510k clearance and a CE mark for its first product.
Who is the founder and CEO of PulmOne?
Avi Lazar is the Founder and CEO of PulmOne.

Team · 1

Avi Lazar
Founder · Founder & CEO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical MonitorsDiagnostics Devices
Technologies
Machinery & Robotics
Target customers
Healthcare & Life SciencesHealthcareProvidersMedical Devices IndustryMedical Equipment
Business model
B2B

Highlights

1 Patents

Tags

hospitalspulmonarydiagnosticsmedical-devicesmonitoringrespiratorydoctorspatent-pendinghealthcare-providersclinics
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)